-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Sell on Dynavax Technologies, Lowers Price Target to $10

Benzinga·04/17/2025 17:35:45
Listen to the news
Goldman Sachs analyst Paul Choi maintains Dynavax Technologies (NASDAQ:DVAX) with a Sell and lowers the price target from $12 to $10.